(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 7.64% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Mckesson's revenue in 2026 is $387,094,000,000.On average, 19 Wall Street analysts forecast MCK's revenue for 2026 to be $50,892,263,741,200, with the lowest MCK revenue forecast at $48,944,961,484,150, and the highest MCK revenue forecast at $53,434,359,024,600. On average, 18 Wall Street analysts forecast MCK's revenue for 2027 to be $55,134,314,275,050, with the lowest MCK revenue forecast at $51,716,136,629,950, and the highest MCK revenue forecast at $58,475,597,117,200.
In 2028, MCK is forecast to generate $59,624,082,095,450 in revenue, with the lowest revenue forecast at $54,766,009,151,450 and the highest revenue forecast at $64,615,949,528,050.